Showing results (31-40 of 487) with videos related to
Sort By:
Pageof 49
Cancer Research|January 1, 1988
Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivoB A Teicher, S A Holden, C A Cucchi, et al.Cancer Research|February 15, 1991
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinomaB A Teicher, T S Herman, J Tanaka, et al.Current Pharmaceutical Design|July 27, 2001
Cryptophycins: a novel class of potent antimitotic antitumor depsipeptidesC Shih, B A TeicherInvestigational New Drugs|January 1, 1997
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agentsY Kakeji, B A TeicherCancer Research|January 15, 1987
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II)B A Teicher, S A Holden, M J Kelley, et al.Cancer Research|September 15, 1989
Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramideB A Teicher, D J Waxman, S A Holden, et al.Science (New York, N.Y.)|March 2, 1984
Perfluorochemical emulsions can increase tumor radiosensitivityB A Teicher, C M RoseRadiation Research|January 1, 1987
Antitumor and radiosensitizing activity of several platinum-(+) dye complexesB A Teicher, S A HoldenInternational Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DAB A Teicher, C M RoseCancer Research|May 15, 1988
Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcomaT S Herman, B A TeicherPageof 49